• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Archives for March 2018

WHO Joint Tropical Disease Program Issues Report On Research Fairness

02/03/2018 by Intellectual Property Watch Leave a Comment

The World Health Organisation’s Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Development, English, Finance, Health & IP, Health Policy Watch, Human Rights, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

Medicines Vastly Overpriced, Generics Too: Discussion At WTO-WIPO-WHO Symposium

02/03/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

The price of hepatitis C medicine marked a turning point in the discussion on access to medicines, with developed countries suddenly confronted to prices they could not afford. This week, a symposium jointly organised by the World Health Organization, the World Trade Organization, and the World Intellectual Property Organization explored the question of the pricing of medicines. A number of suggestions were made to alleviate the issue, such as ensuring wide use of generic medicines, encouraging competition, and alerting countries about the cost of medicine production so they negotiate better with pharmaceutical companies.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO, WIPO, WTO/TRIPS

Study: TRIPS Flexibilities Widely Used By Countries, Contrary To Reports

02/03/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

Despite the widespread view that the flexibilities included in international trade rules are not often used, a new study found that countries make extensive use of those flexibilities.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

EU Commission Proposes Measures Against Illegal Online Content Including IP Infringement

01/03/2018 by William New, Intellectual Property Watch Leave a Comment

The European Commission today recommended a set of operational measures against a wide range of online content considered illegal, lumping intellectual property rights-infringing material in with that of terrorists, child sexual abusers, hate speech, and commercial scams.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, Enforcement, English, Europe, Information and Communications Technology/ Broadcasting, Regional Policy

Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification

01/03/2018 by Intellectual Property Watch Leave a Comment

Teens’ (and others’) life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called “gaming disorder.” Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from “preeminent researchers and scientists” that it says casts doubt on the WHO’s efforts.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Copyright Policy, Enforcement, English, Health Policy Watch, Lobbying, WHO

USPTO Rejects Use Of Tribal Sovereign Immunity In Allergan Patent Deal

01/03/2018 by Dugie Standeford for Intellectual Property Watch 1 Comment

Native American tribes’ sovereign immunity can’t be used to avoid inter partes review (IPR) of patent validity, the US Patent and Trademark Office Patent and Appeal Board (PTAB) has ruled in a first-of-its-kind case.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, IP Law, North America, Patents/Designs/Trade Secrets, Regional Policy

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting